UK markets close in 4 hours 37 minutes

ANI Pharmaceuticals, Inc. (ANIP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
63.77-1.05 (-1.62%)
At close: 04:00PM EDT
63.77 0.00 (0.00%)
After hours: 04:03PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
517,460
486,816
316,385
216,136
208,475
Cost of revenue
192,962
181,513
138,785
100,610
87,157
Gross profit
324,498
305,303
177,600
115,526
121,318
Operating expenses
Research development
38,873
34,286
22,318
11,369
16,001
Selling general and administrative
173,250
161,697
124,044
84,294
64,986
Total operating expenses
271,900
255,774
203,334
143,695
136,888
Operating income or loss
52,598
49,529
-25,734
-28,169
-15,570
Interest expense
23,844
26,940
28,052
11,922
9,452
Total other income/expenses net
14,288
-2,717
-8,879
-15,967
-940
Income before tax
43,042
19,872
-62,665
-56,058
-25,962
Income tax expense
7,495
1,093
-14,769
-13,455
-3,414
Income from continuing operations
35,547
18,779
-47,896
-42,603
-22,548
Net income
35,547
18,779
-47,896
-42,603
-22,548
Net income available to common shareholders
33,922
17,154
-49,521
-42,793
-22,548
Basic EPS
0.55
0.86
-3.05
-3.40
-1.88
Diluted EPS
0.54
0.85
-3.05
-3.40
-1.88
Basic average shares
17,329
18,001
16,260
12,596
11,964
Diluted average shares
17,449
18,194
16,260
12,596
11,964